Precision Medicine

Optimizing Cancer Care Pathways Through Precision Medicine, RWD

December 5, 2023 - Personalized medicine is vital because it streamlines clinical decision-making through genetic tests or biomarkers. Essentially, personalized care lets caregivers feel more confident that a patient will respond to a specific drug or be less likely to have an adverse reaction to another.  However, personalized medicine relies on a plethora of patient data to determine those...

Read More


More Articles

Understanding Implications of Pharmacogenomic on Prescribing

by Veronica Salib

Pharmacogenomic research explores how specific genes or genetic variations can impact drug responses and treatment outcomes. While not a standard of care, pharmacogenomic testing can significantly impact prescribing and medication safety....

National Cancer Institute Launches Precision Medicine Initiative

by Veronica Salib

On June 1, 2023, the National Cancer Institute (NCI), a subset of the NIH, launched ComboMATCH, a precision medicine initiative for cancer patients. ComboMATCH — short for Combination Therapy...

Nectin Therapeutics Collaborates with Merck on Cancer Treatment

by Veronica Salib

Earlier this year, Nectin Therapeutics Ltd, a clinical biotechnology company, announced a collaboration with Merck, a leading global pharmaceutical company, to develop a treatment regimen for cancer patients. The clinical trial combines a...

How Brain-in-a-Dish Technology Can Impact the Treatment of MDD

by Veronica Salib

According to the WHO, major depressive disorder (MDD) is the most common illness, affecting approximately 280 million people worldwide. That said, treating depression presents a unique challenge for providers. With several medications...

Michigan Blue Launches Pharmacogenomics Precision Medicine Program

by Alivia Kaylor

Blue Care Network recently announced the launch of Michigan’s first end-to-end pharmacogenomics precision medicine program, Blue Cross Personalized Medicine. This program leverages genetic...

Boehringer Ingelheim, Lifebit Partner to Advance Biomedical Data

by Samantha McGrail

Boehringer Ingelheim and precision medicine software company Lifebit Biotech recently partnered to build a scalable data, analytics, and infrastructure platform to unlock the transformation value of...

Prices of Brand Name Migraine Medications Continue to Increase

by Samantha McGrail

Although prices for migraine medications rose by 40 percent through 2017, they sharply declined at the beginning of 2018 and haven’t seen much of an increase since, according to a GoodRx report....

National Academy of Medicine Presents COVID-19 Vaccine Framework

by Samantha McGrail

The National Academies of Sciences, Engineering, and Medicine recently released a discussion draft of a preliminary framework to assist policymakers in planning for equitable allocation of a COVID-19...

Pharma Company Earns $311M for Cannabinoid Medicines

by Samantha McGrail

GW Pharmaceuticals announced last week that its cannabinoid (CBD) prescription medicines brought in total revenue of $109.1 million for the fourth quarter of 2019, and $311.3 million for the full...

Children’s Hospitals Team Up to Link Patients to Clinical Trials

by Samantha McGrail

Michigan Medicine’s C.S. Mott Children’s Hospital recently announced that it has joined the top children’s hospitals from the United States, Canada, Australia, and Europe to...

GAO Backs Machine Learning in Drug Development

by Ana Mulero

The Government Accountability Office unveiled a report on Tuesday that identifies challenges and opportunities with the use of machine learning throughout the drug development lifecycle.  Machine...

Recent Articles